Condition

Breast Cancer Female NOS

ClinicalTrials.gov condition label

Clinical trials6

Recruiting1

Common interventions12

Lead sponsors shown3

Clinical trials

6 shown

Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBCNCT07290153 · 2026-01-01

Effect of an Educational Intervention in Women With Breast Cancer (EDU-INT-BC)NCT07367074 · 2026-01-26

Denosumab as an add-on Neoadjuvant Treatment (GeparX)NCT02682693 · 2017-02-13

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)NCT02125344 · 2014-12-01

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)NCT01583426 · 2012-07-01

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast CancerNCT01426880 · 2011-08-01

Common interventions

CarboplatinDRUG3 CyclophosphamideDRUG2 EpirubicinDRUG2 nab-PaclitaxelDRUG2 PaclitaxelDRUG2 PertuzumabDRUG2 TrastuzumabDRUG2 background treatmentDRUG1 DenosumabDRUG1 Ferric carboxymaltoseDRUG1 non-pegylated liposomal doxorubicinDRUG1 Therapeutic Education Program for Women With Breast CancerBEHAVIORAL1

Leading sponsors

GBG Forschungs GmbH4 Fudan University1 Instituts Supérieurs des Professions Infirmières et Techniques de Santé, Morocco1

Trial status mix

COMPLETED5

RECRUITING1

Phase mix

PHASE33

PHASE22

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.